None
Quote | Artelo Biosciences Inc. (OTCMKTS:ARTL)
Last: | $ |
---|---|
Change Percent: | 2.11% |
Open: | $1.58 |
Close: | $1.45 |
High: | $1.58 |
Low: | $1.45 |
Volume: | 48,173 |
Last Trade Date Time: | 02/12/2020 04:34:00 pm |
News | Artelo Biosciences Inc. (OTCMKTS:ARTL)
SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condit...
Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a c...
Message Board Posts | Artelo Biosciences Inc. (OTCMKTS:ARTL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RMED News Article - Ra Medical Electrophysiology Division is Participating in EHRA Con | whytestocks | investorshangout | 04/17/2023 12:35:59 PM |
Added | heyitsmeagain | investorshub | 04/03/2023 5:45:12 PM |
Im back ! Im in pamp | heyitsmeagain | investorshub | 03/31/2023 8:12:14 PM |
whytestocks: $RMED News Article - Ra Medical Systems Announces Date of Special Shareholder Meeting | whytestocks | investorshangout | 02/10/2023 6:05:48 PM |
whytestocks: $RMED News Article - Ra Medical Systems Announces the Presentation of Clinical Data at | whytestocks | investorshangout | 01/23/2023 3:50:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Artelo Biosciences Inc. Company Name:
ARTL Stock Symbol:
OTCMKTS Market:
Artelo Biosciences Inc. Website:
SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condit...
Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a c...
SOLANA BEACH, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condit...